Age-stratified outcomes favored adolescents (48.6% SALT ≤20) versus adults (21.9%), plausibly related to shorter disease duration, shorter current episode, and greater follicular regenerative capacity ...
New partnerships and in-state capabilities are reducing the need for cross-market travel while expanding access to CAR T-cell ...
Kerry Rogers, MD, breaks down the clinical and lifestyle factors that drive frontline treatment selection between BTK ...
Sequencing CAR T-cell therapy versus bispecific antibodies in myeloma increasingly hinges on MRD depth, transplant candidacy, ...
A study led by Meng-Han Tsai, PhD, found that men and racial and ethnic minority patients with early-onset CRC in urban areas face a higher CVD death risk. There's a term we call “cardio-oncology” ...
Jonathan Wrathall, PhD, explains that his 2 studies found social needs and insurance type strongly predicted food insecurity.
Of the 3 primary breast cancer subtypes (estrogen receptor [ER]–positive, HER2-positive, and triple negative), the recent ...
Improved BTK selectivity with zanubrutinib is associated with fewer off-target toxicities that commonly limit ibrutinib, ...
Pharmacists need better support to manage emotional strain tied to patient suffering, treatment costs, and care decisions, says Karen Fancher, PharmD, BCOP. Fancher explained that her interest in ...
Cost advantages concentrated in higher OOP tiers: only 15% of all prescriptions were cheaper, but MCCPDC undercut insurance for ~82% of fills when OOP exceeded $15. Therapeutic areas with frequent ...
Epidemiology links AA and atopy: up to 40% of AA patients have atopic comorbidities, and concurrent AD predicts poorer response and relapse. Immune profiling shows mixed Th1/Th2/Th22 activation with ...
Texas Oncology boosts precision medicine with near-universal biomarker testing, quality measurement, and genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results